Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis.

Histopathology - 1 Dec 2013

Morgado José M, Perbellini Omar, Johnson Ryan C, Teodósio Cristina, Matito Almudena, Álvarez-Twose Iván, Bonadonna Patrizia, Zamò Alberto, Jara-Acevedo Maria, Mayado Andrea, Garcia-Montero Andrés, Mollejo Manuela, George Tracy I, Zanotti Roberta, Orfao Alberto, Escribano Luis, Sánchez-Muñoz Laura

Abstract excerpt

AIMS: CD30 expression by bone marrow (BM) mast cells (MC) has been reported recently in systemic mastocytosis (SM) patients. The aim of this study was to investigate the potential diagnostic and prognostic value of CD30 expression in SM as assessed by multiparameter flow cytometry. METHODS AND RESULTS: A total of 163 consecutive BM samples corresponding to 142 SM patients and 21 non-mastocytosis cases were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Marrow Cells
Share to Diagnosis, Differential

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunophenotyping

Share to Interleukin-2 Receptor alpha Subunit

Share to Ki-1 Antigen

Share to Mast Cells

Share to Mastocytosis, Systemic

Share to Proto-Oncogene Proteins c-kit

Source

Identifiers

PMID: 24111625
DOI: 10.1111/his.12221

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis.PMID 24111625Read ↗

Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosis.Semantic proximity Read ↗

Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis.Semantic proximity Read ↗

Prevalence of CD30 immunostaining in neoplastic mast cells: A retrospective immunohistochemical study.Semantic proximity Read ↗

Systemic mastocytosis with associated clonal hematologic nonmast cell lineage disease: a clinicopathologic review.Semantic proximity Read ↗

Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes.Semantic proximity Read ↗

Primary role of multiparametric flow cytometry in the diagnostic work-up of indolent clonal mast cell disorders.Semantic proximity Read ↗

Current state of biology and diagnosis of clonal mast cell diseases in adults.Semantic proximity Read ↗

Mastocytosis and related disorders.Semantic proximity Read ↗

Bone Marrow Expression of Mast Cell Disorders.Semantic proximity Read ↗

Distinct clinical, laboratory, molecular, and pathologic features of systemic mastocytosis involving the gastrointestinal tract.Semantic proximity Read ↗

Well-differentiated systemic mastocytosis showed excellent clinical response to imatinib in the absence of known molecular genetic abnormalities: A case report.Semantic proximity Read ↗

Utility of KIT Mutations in Myeloid Neoplasms Without Documented Systemic Mastocytosis to Detect Hidden Mast Cells in Bone Marrow.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.